13.8
Aperçu sur les anesthésiques par inhalation :
Les anesthésiques par inhalation sont des médicaments qui induisent une anesthésie générale lors de leur inhalation. Ils agissent en augmentant la sen…
Les anesthésiques par inhalation induisent une anesthésie générale par l’inhalation de gaz et de liquides volatils qui se diffusent rapidement dans les alvéoles pulmonaires et les tissus.
Le pouvoir anesthésique de ces agents dépend de la concentration alvéolaire minimale. La distribution de ces anesthésiques implique un lavage alvéolaire, suivi d’une absorption tissulaire rapide.
Ils présentent des courbes dose-réponse abruptes et des indices thérapeutiques étroits sans antagonistes connus.
Les agents modernes englobent les liquides volatils tels que l’isoflurane, le desflurane, le sévoflurane et les gaz comme le protoxyde d’azote. Ils sont ininflammables, non explosifs et livrés via un système de recirculation pour minimiser les déchets.
Ces agents diminuent la résistance cérébrovasculaire et la pulsion respiratoire en renforçant l'action du GABA sur les récepteurs GABAA, à l'exception du protoxyde d'azote, qui inhibe les récepteurs NMDA.
Ces agents ont des effets indésirables potentiels tels que l’hypotension, l’irritation respiratoire et la néphrotoxicité. L’exposition aux hydrocarbures halogénés peut déclencher une hyperthermie maligne, une maladie rare et potentiellement mortelle.
Notamment, comme la plupart des anesthésiques par inhalation sont libérés sous forme inchangée dans l’atmosphère, ils ont un impact grave sur l’environnement.
View the full transcript and gain access to JoVE Core videos
Q1: How do inhalational anesthetics induce general anesthesia?
Inhalational anesthetics induce general anesthesia through inhaled gases and volatile liquids that diffuse rapidly across pulmonary alveoli into tissues. Most agents enhance GABA's action on GABAA receptors, decreasing central nervous system activity. Nitrous oxide uniquely inhibits NMDA receptors instead. The depth of anesthesia can be rapidly adjusted by changing the inhaled gas concentration.
Q2: What is minimum alveolar concentration and why does it matter?
Minimum alveolar concentration (MAC) is the measure of anesthetic potency, determining how much inhaled anesthetic is needed for effect. It varies based on patient factors like age, temperature, and concurrent drug use. Agents with lower MAC values are more potent. This metric helps clinicians select appropriate anesthetics and dosing for individual patients.
Q3: What are the main types of modern inhalational anesthetics?
Modern inhalational anesthetics include volatile liquids such as isoflurane, desflurane, and sevoflurane, plus gases like nitrous oxide. Isoflurane causes dose-dependent hypotension with a pungent odor. Desflurane offers rapid onset and recovery due to low blood solubility. Sevoflurane has low pungency and is preferred for pediatric inhalation induction.
Q4: What adverse effects are associated with inhalational anesthetics?
Inhalational anesthetics can cause hypotension, respiratory irritation, and organ toxicity including nephrotoxicity. Exposure to halogenated hydrocarbons may trigger malignant hyperthermia, a rare but life-threatening condition. Metabolism can generate toxic metabolites, prompting replacement with less toxic alternatives. These risks require careful patient selection and monitoring during anesthesia.
Q5: Why are inhalational anesthetics a concern for the environment?
Most inhalational anesthetics are released unchanged into the atmosphere as greenhouse gases, contributing to global warming and climate change. Their environmental persistence and potency as climate agents have prompted efforts to minimize their use and atmospheric release. This environmental impact influences anesthetic selection in clinical practice.
Q6: How are inhalational anesthetics distributed and delivered in the body?
Inhalational anesthetics distribute through alveolar wash-in followed by rapid tissue uptake. They exhibit steep dose-response curves and narrow therapeutic indices ranging from 2 to 4, with no known antagonists. Modern agents are delivered via recirculation systems to minimize waste. This distribution pattern allows rapid onset and offset of anesthetic effects.
Q7: What factors influence the selection of a specific inhalational anesthetic?
Selection involves balancing the patient's pathophysiology against the drug's side-effect profile. Clinicians consider factors like age, temperature, concurrent medications, and the procedure duration. Sevoflurane is preferred for pediatric patients due to low pungency, while desflurane suits short procedures. The goal is maintaining optimal brain partial pressure while minimizing adverse effects.